Anchiano Therapeutics Aktie - ANCN

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

4,71

Gebot

5,10

Fragen

5,15

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

Handelsende

4,71

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

Erlöse

Nettogewinn

-24,22M

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.chemomab.com

Hauptsitz

Tel Aviv, Center, Isr

Gegründet

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano shareholders approve all resolutions at shareholder meeting The merged company is expected to receive...

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for...

Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange

CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

ANCN - Frequently Asked Questions (FAQ)

What is the current Anchiano Therapeutics share price?

The current share price of Anchiano Therapeutics is US$ 4,71

What is the 1 year trading range for Anchiano Therapeutics share price?

Anchiano Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the reporting currency for Anchiano Therapeutics?

Anchiano Therapeutics reports financial results in USD

What is the latest annual profit for Anchiano Therapeutics?

The latest annual profit of Anchiano Therapeutics is USD -24,22M

What is the registered address of Anchiano Therapeutics?

The registered address for Anchiano Therapeutics is KIRYAT ATIDIM, BUILDING 7, TEL AVIV, CENTER, 6158002

What is the Anchiano Therapeutics website address?

The website address for Anchiano Therapeutics is www.chemomab.com

Which industry sector does Anchiano Therapeutics operate in?

Anchiano Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
NWTNNWTN Inc	US$ 0,7717 (45,33%)	3,38M
NAOVNanoVibronix Inc	US$ 2,91 (31,92%)	231,32k
QSIQuantum Si Inc	US$ 1,72 (26,47%)	8,08M
SBETSharpLink Gaming Inc	US$ 0,42 (17,91%)	1,45M
OVIDOvid Therapeutics Inc	US$ 0,492 (13,39%)	1,99k
ILAGIntelligent Living Application Group Inc	US$ 0,4012 (-14,46%)	532
BHATBlue Hat Interactive Entertainment Technology	US$ 0,024 (-11,11%)	5,72M
XWELXWELL Inc	US$ 0,9405 (-10,43%)	724
XAGELongevity Health Holdings Inc	US$ 0,2226 (-10,02%)	27,72k
AWHAspira Womans Health Inc	US$ 0,1264 (-9,71%)	11,36M
ADTXAditxt Inc	US$ 0,0217 (7,96%)	85,56M
HEPAHepion Pharmaceuticals Inc	US$ 0,0238 (3,48%)	23,86M
AWHAspira Womans Health Inc	US$ 0,1264 (-9,71%)	11,36M
QSIQuantum Si Inc	US$ 1,72 (26,47%)	8,08M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,024 (-11,11%)	5,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Anchiano Therapeutics Ltd (ANCN)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Anchiano Therapeutics Ltd

ANCN Neueste Nachrichten

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange

ANCN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Anchiano Therapeutics Ltd (ANCN) Börsenkurse

Anchiano Therapeutics Ltd (ANCN)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Anchiano Therapeutics Ltd

ANCN Neueste Nachrichten

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange

ANCN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR